Encourages use of exact change for purchases. In a video posted Monday on Twitter, the Director of the U.S. Mint, David Ryder, called for Americans to help fight…
Read MoreCoronavirus
Convalescent Plasma for COVID-19 Approved by FDA
Operation Warp Speed credited with the accelerated timeline. President Trump announced during a press conference Sunday evening that the FDA has granted an emergency use authorization for convalescent…
Read More
Vaccine Trials on Volunteers to Begin Next Month
Johnson & Johnson plans test on 60,000 people. Tests on its experimental coronavirus vaccine in a late-stage trial are scheduled to start in September with Johnson & Johnson…
Read More
President Trump Travels to Pennsylvania
Holds campaign event and speaks to voters in the Scranton area. On Thursday, President Trump took part in campaign event in the town of Old Forge, Pennsylvania. He…
Read More
IRS Returns Owed Interest
Nearly 14 million taxpayers to receive funds. The Department of the Treasury announced on Thursday that the Internal Revenue Service (IRS) would be returning over $12 million of…
Read MoreU.S. and China Trade Talks Postponed
They had plans to review progress of Phase I deal. According to Chinese officials, senior American and Chinese negotiators will soon discuss progress on the first phase trade…
Read More
HUD to Halt Evictions and Foreclosures
Nearly 8.1 million people have FHA loans. The Department of Housing and Urban Development will halt evictions and foreclosures for owners with FHA loans through the end of…
Read More
New Doctor Joins COVID-19 Task Force
Dr. Atlas expected to align more closely with the president. Last week, President Trump announced that Dr. Scott Atlas would be joining the White House’s task force to…
Read More
CDC Report Underscores Mental Health Concerns
Health officials warning of the impact of COVID-19 measures. As the U.S. grapples with the effects of the shutdown during the pandemic, health experts have been identifying one…
Read More
FDA’s Plasma Program Data Lacks Cohesion
Informal study hampered by greater than anticipated participation of COVID-19 patients. The U.S. Food and Drug Administration designed a plasma program to try and speed along potential research…
Read More